These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3466 related articles for article (PubMed ID: 22674330)

  • 1. Host-gut microbiota metabolic interactions.
    Nicholson JK; Holmes E; Kinross J; Burcelin R; Gibson G; Jia W; Pettersson S
    Science; 2012 Jun; 336(6086):1262-7. PubMed ID: 22674330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk.
    Holmes E; Li JV; Marchesi JR; Nicholson JK
    Cell Metab; 2012 Nov; 16(5):559-64. PubMed ID: 23140640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota and the metabolic health of the host.
    Joyce SA; Gahan CG
    Curr Opin Gastroenterol; 2014 Mar; 30(2):120-7. PubMed ID: 24468803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota drives metabolic disease in immunologically altered mice.
    Chassaing B; Aitken JD; Gewirtz AT; Vijay-Kumar M
    Adv Immunol; 2012; 116():93-112. PubMed ID: 23063074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
    Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, host health, and polysaccharides.
    Xu X; Xu P; Ma C; Tang J; Zhang X
    Biotechnol Adv; 2013; 31(2):318-37. PubMed ID: 23280014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic interplay between gut bacteria and their host.
    Duca F; Gérard P; Covasa M; Lepage P
    Front Horm Res; 2014; 42():73-82. PubMed ID: 24732926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of metabolism: a cross talk between gut microbiota and its human host.
    Burcelin R
    Physiology (Bethesda); 2012 Oct; 27(5):300-7. PubMed ID: 23026753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota and the immune system in metabolic diseases.
    Sittipo P; Lobionda S; Lee YK; Maynard CL
    J Microbiol; 2018 Mar; 56(3):154-162. PubMed ID: 29492872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-metabolome network of carbohydrate metabolism: interactions between gut microbiota and host.
    Ibrahim M; Anishetty S
    Biochem Biophys Res Commun; 2012 Nov; 428(2):278-84. PubMed ID: 23085046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crosstalk between gut microbiota and obesity and related metabolic disorders.
    Xu WT; Nie YZ; Yang Z; Lu NH
    Future Microbiol; 2016 Jun; 11():825-36. PubMed ID: 27192213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
    Xie G; Zhang S; Zheng X; Jia W
    Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease.
    Holmes E; Li JV; Athanasiou T; Ashrafian H; Nicholson JK
    Trends Microbiol; 2011 Jul; 19(7):349-59. PubMed ID: 21684749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 174.